Brigham Michael F

Avg. Two Year Performance

135% Avg. Purchase Return

53% Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	47%	28%	99%	166%	135%
Purchase Success Rate	3 of 3	1 of 3	2 of 3	1 of 3	2 of 3
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

ImmuCell Corp.

Drugs » Diagnostic Substances

President & CEO, Director:

Holdings: 204.75K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--